Cargando…
Therapeutic potential of parkin as a tumor suppressor via transcriptional control of cyclins in glioblastoma cell and animal models
Parkin (PK) is an E3-ligase harboring tumor suppressor properties that has been associated to various cancer types including glioblastoma (GBM). However, PK is also a transcription factor (TF), the contribution of which to GBM etiology remains to be established. Methods: The impact of PK on GBM cell...
Autores principales: | Rouland, Lila, Duplan, Eric, Ramos dos Santos, Lígia, Bernardin, Aurore, Katula, Karen S., Manfioletti, Guidalberto, Idbaih, Ahmed, Checler, Frédéric, Alves da Costa, Cristine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581414/ https://www.ncbi.nlm.nih.gov/pubmed/34815803 http://dx.doi.org/10.7150/thno.57549 |
Ejemplares similares
-
The Transcription Factor Function of Parkin: Breaking the Dogma
por: Alves da Costa, Cristine, et al.
Publicado: (2019) -
Direct α-synuclein promoter transactivation by the tumor suppressor p53
por: Duplan, Eric, et al.
Publicado: (2016) -
Parkin as a Molecular Bridge Linking Alzheimer’s and Parkinson’s Diseases?
por: Checler, Frédéric, et al.
Publicado: (2022) -
Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation
por: Goiran, Thomas, et al.
Publicado: (2018) -
The transcription factor XBP-1 in neurodegenerative diseases
por: Checler, Frédéric, et al.
Publicado: (2013)